Shares of Solid Biosciences (SLDB) stock dropped to all-time lows on Thursday, falling as low as $5.97. SLBD stock closed… Read More >
-
Solid Biosciences Inc (SLDB)
$8.96 | $0.46 (5.13%)
-
Dividend Yield
0.00% -
SSR Rating
28
Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Solid Biosciences, lead product candidate the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
-
Last Price:$8.96
-
Previous Close:$8.50
-
Change:$0.46 (5.41%)
-
Open:$8.73
-
Volume:1,055,379
-
Average Volume (100 Day):560,080
-
Market Capitalization:$317.5 M
-
Day's Range:$8.50 - $9.12
-
Dividend Yield:0.00%
-
52-week Range:$55 - $5.97
-
P-E:0.00
-
EPS:$-1.61
-
Earnings Date:4/4/19
-
Ex Dividend Date:N/A
-
Sector:Healthcare
-
Industry:Drug Manufacturers - Specialty & Generic